UPDATE: Regeneron Pharma (REGN) PT Raised to $675 at Oppenheimer Due to Success of Assets, Especially Eylea
Tweet Send to a Friend
(Updated - July 1, 2020 12:08 PM EDT)
(updated to add analyst comments)Oppenheimer analyst Hartaj Singh raised the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Oppenheimer analyst Hartaj Singh raised the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
